Drug class · Pain & inflammation
Opioid agonists
Drugs that activate opioid receptors. Most are DEA-scheduled; the schedule is shown on each NDC record.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Morphine Sulfate | Morphine sulfate 1 mg/30mL | InjectionIntravenous | International Medication Systems, Limited | 76329-1912 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | TabletOral | SpecGx LLC | 0406-5119 |
| Morphine Sulfate | Morphine sulfate 10 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0225 |
| Morphine Sulfate | Morphine sulfate 15 mg/1 | TabletOral | Redpharm Drug | 67296-2122 |
| Morphine Sulfate | Morphine sulfate 15 mg/1 | TabletOral | Redpharm Drug | 67296-2122 |
| Morphine Sulfate | Morphine sulfate 20 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1277 |
| Morphine Sulfate | Morphine sulfate 10 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-4955 |
| Morphine Sulfate | Morphine sulfate 20 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0226 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0227 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1278 |
| Morphine Sulfate | Morphine sulfate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0641-6191 |
| Morphine Sulfate | Morphine sulfate 20 mg/5mL | SolutionOral | Hikma Pharmaceuticals USA Inc. | 0054-0238 |
| Morphine Sulfate | Morphine sulfate 50 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1279 |
| Morphine Sulfate | Morphine sulfate 4 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0641-6192 |
| Morphine Sulfate | Morphine sulfate 50 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0228 |
| Morphine Sulfate | Morphine sulfate 60 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0229 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | Tablet, Film coated, Extended releaseOral | Bryant Ranch Prepack | 63629-4484 |
| Morphine Sulfate | Morphine sulfate 80 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1281 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | TabletOral | Hikma Pharmaceuticals USA Inc. | 0054-0236 |
| Morphine Sulfate | Morphine sulfate 80 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0230 |
| Morphine Sulfate | Morphine sulfate 10 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-0904 |
| Morphine Sulfate | Morphine sulfate 100 mg/1 | Capsule, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0832-0233 |
| Morphine Sulfate | Morphine sulfate 100 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1282 |
| Morphine Sulfate | Morphine sulfate 5 mg/mL | Injection, SolutionIntramuscular, Intravenous | Fresenius Kabi, USA LLC | 76045-006 |
| Morphine Sulfate | Morphine sulfate 2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Fresenius Kabi, USA LLC | 76045-004 |